Unilateral plyometric training effectively reduces lower limb asymmetry in athletes: a meta-analysis

单侧增强式训练能有效减少运动员下肢不对称:一项荟萃分析

阅读:1

Abstract

BACKGROUND: Lower limb asymmetry in athletes is associated with impaired performance and elevated injury risk. Plyometric training (PT) and complex training (CT) are commonly used interventions for this problem, but existing evidence on their effectiveness remains inconsistent. OBJECTIVE: This meta-analysis aimed to evaluate PT and CT's effects on athletes' lower limb asymmetry. The findings could help optimize training protocols and reduce the risk of sports injuries. METHODS: A systematic search of Web of Science, PubMed, ProQuest, Scopus, EBSCO, CNKI, and Wanfang databases was conducted up to March 2024. Two researchers independently performed the literature screening, data extraction, and quality assessment processes. A meta-analysis was conducted via Review Manager 5.3 software, including heterogeneity tests, effect size pooling, subgroup analysis, and funnel plot construction. RESULTS: A total of eight randomized controlled trials (RCTs) involving 157 participants were included. PT effectively reduced lower limb asymmetry, particularly improving single-leg countermovement jump (SLCMJ) (SMD = 0.51, P = 0.05), single-leg broad jump (SLBJ) (SMD = 0.56, P = 0.01), and single-leg lateral jump (SLLJ) (SMD = 1.24, P = 0.01), but did not affect single-leg horizontal triple jumps (SLH3J) (SMD = 0.24, P = 0.60). In contrast, CT showed no meaningful reduction in asymmetry. Subgroup analysis indicated that unilateral PT alone significantly decreased asymmetry (SMD = 0.71, P < 0.01), whereas bilateral PT (SMD = 0.23, P = 0.45), unilateral CT (SMD = -0.15, P = 0.15) and bilateral CT (SMD = -0.09, P = 0.78) interventions all failed to demonstrate efficacy. CONCLUSION: Unilateral PT effectively reduces lower limb asymmetry in athletes. Coaches should integrate this method into training programs to address asymmetry-related performance deficits and injury risks. Further high-quality trials are required to validate clinical applicability.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。